天地源(600665.SH)下屬重慶天投5.38億元競得重慶市一宗二類居住用地
格隆匯 12 月 23日丨天地源(600665.SH)公佈,2020年12月23日,公司下屬重慶天投房地產開發有限公司通過競買方式,以總價5.38億元獲取了重慶市九龍坡區大楊石組團Q標準分區QE4-2/05地塊的國有建設用地使用權。
重慶市九龍坡區大楊石組團Q標準分區QE4-2/05地塊位於九龍坡區大楊石組團。地塊東北側緊鄰恆勝立交,北側緊鄰火炬大道,東側緊鄰翼龍路,西側臨金科西城大院,南側鄰綠雲鋼材市場。建設用地面積26,175平方米,計容建築面積52,350平方米,容積率≤2.0,土地性質為二類居住用地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.